ResMed | RMD - Market Capitalization

Stock Price
219.85
Daily Change
0.34 0.15%
Monthly
-2.85%
Yearly
-6.80%
Q2 Forecast
215.15

ResMed reported $32.14B in Market Capitalization this April of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Ansell USD 3.36B 450.92M Dec/2025
Artivion USD 2.18B 176M Dec/2025
AtriCure USD 1.97B 215M Dec/2025
Baxter International USD 9.82B 1.87B Dec/2025
Cochlear AUD 17.05B 2.6B Dec/2025
Cooper Companies USD 15.95B 2.05B Dec/2025
CSL USD 55.89B 20.42B Dec/2025
Dexcom USD 25.88B 503M Dec/2025
Edwards Lifesciences USD 47.05B 884M Apr/2026
Fisher Paykel Healthcare NZD 21.76B 2.1B Dec/2025
Globus Medical USD 11.69B 3.95B Dec/2025
Haemonetics USD 3.76B 1.44B Dec/2025
Idexx Laboratories USD 54.02B 2.91B Dec/2025
Insulet USD 20B 1.74B Dec/2025
Integra LifeSciences USD 967M 150M Dec/2025
Intuitive Surgical USD 159.96B 3.77B Apr/2026
Masimo USD 6.84B 839M Dec/2025
Philips EUR 22.38B 192.58M Dec/2025
Ramsay Health Care AUD 7.93B 537.83M Dec/2025
ResMed USD 35.16B 4.79B Dec/2025
Sigma Healthcare AUD 2.7B 1.99B Apr/2026
Sonic Healthcare AUD 11.17B 1.7B Dec/2025
Steris USD 24.88B 511M Dec/2025
Teleflex USD 5.39B 91M Dec/2025
Thermo Fisher Scientific USD 177.96B 4.7B Apr/2026